Rituximab-treated patients with MS may be vaccinated for COVID-19 as soon as possible, researchers reported in JAMA Network Open.
Rituximab-treated patients with MS may be vaccinated for COVID-19 as soon as possible, researchers reported in JAMA Network Open.
HealthGility provides healthcare organizations with a solution for protected patient health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.